DiaMedica Therapeutics Inc. Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
CEORick John Pauls
CEORick John Pauls
Employees28
Employees28
HeadquartersMinneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded2000
Founded2000
Employees28
Employees28
DMAC Key Statistics
Market cap156.95M
Market cap156.95M
Price-Earnings ratio-5.65
Price-Earnings ratio-5.65
Dividend yield—
Dividend yield—
Average volume113.39K
Average volume113.39K
High today$3.94
High today$3.94
Low today$3.65
Low today$3.65
Open price$3.85
Open price$3.85
Volume112.43K
Volume112.43K
52 Week high$6.82
52 Week high$6.82
52 Week low$2.14
52 Week low$2.14
DMAC News
Simply Wall St 2h
DiaMedica Therapeutics Insiders Up US$4.1m On US$9.00m InvestmentDiaMedica Therapeutics Inc. ( ) insiders who acquired shares over the previous 12 months, can probably afford to ignore the recent 12% decline in the stock pric...
People also own
Based on the portfolios of people who own DMAC. This list is generated using Robinhood data, and it’s not a recommendation.